ALMR - CIK 0002104204
The table below shows Alamar Biosciences, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 |
|---|---|---|
| Operating cash flow | -$20.35M | -$13.07M |
| Capital expenditure | $600.00K | $554.00K |
| Investing cash flow | -$778.00K | $17.02M |
| Dividends paid | - | - |
| Stock buybacks | - | - |
| Financing cash flow | $55.76M | $243.00K |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.